Latest Schedule 13G passive stakes

T. Rowe Price Investment Management, Inc. has disclosed beneficial ownership of 10.5% of Planet Fitness Inc.'s common stock as of June 30, 2026.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting a beneficial ownership of 15.3% in Shattuck Labs Inc. common stock as of June 30, 2026.

T. Rowe Price Investment Management, Inc. has amended its Schedule 13G filing to report a beneficial ownership of 18.1% in Aurora Innovation Inc. as of June 30, 2026.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 4.6% of Sportradar Group AG's common stock.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 1,568,820 shares, representing 8.6% of USCB Financial Holdings' common stock.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.9% of M-TRON INDUSTRIES INC's common stock as of June 30, 2026.

T. Rowe Price Investment Management, Inc. has updated its beneficial ownership filing for QuidelOrtho Corp., reporting a 2.6% stake.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.0% of Revvity Inc.'s common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed an amendment to its Schedule 13G, reporting its beneficial ownership of Repligen Corp. common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, disclosing a beneficial ownership of 5,428,244 shares, representing 4.9% of Quest Diagnostics Inc.'s common stock.

T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 6.6% of Descartes Systems Group's common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 2,222,444 shares, representing 6.2% of Novanta Inc.'s common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 12.5% of Expro Group Holdings NV's common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.8% of United States Antimony Corp.'s common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, disclosing beneficial ownership of 6.1% of Fulton Financial Corp.'s common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.0% of Celldex Therapeutics' common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 7.0% of Vicor Corp's common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has updated its Schedule 13G filing to reflect beneficial ownership of 5.2% of Hanover Insurance Group Inc.'s common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has disclosed beneficial ownership of 6.6% of SLM Corp's common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has reported a beneficial ownership of 5.3% in Build-A-Bear Workshop Inc., holding 669,597 shares.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.8% of Western Alliance Bancorp's common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, disclosing a beneficial ownership of 5.9% in Ambarella Inc. common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has updated its beneficial ownership filing for CF Industries Holdings Inc., now holding 5.5% of the common stock.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5,372,456 shares, representing 4.5% of Booz Allen Hamilton Holdings' common stock.

T. Rowe Price Associates, Inc. has updated its beneficial ownership filing for Kodiak Sciences Inc., reporting a 5.2% stake as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.6% of Sensata Technologies Holding's common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 5.6% of Keysight Technologies' common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed an amendment to its Schedule 13G, reporting its beneficial ownership of Wingstop Inc. common stock.

T. Rowe Price Associates, Inc. has updated its Schedule 13G filing to reflect beneficial ownership of 5.6% of Rocket Companies, Inc. Class A common stock as of June 30, 2026.

Baron Capital Group, along with its affiliates, has reported an amendment to its Schedule 13G filing, indicating a change in its beneficial ownership of CareDx, Inc. common stock.